梗阻性肥厚型心肌病-话题@MedSci - 梅斯（MedSci）

#梗阻性肥厚型心肌病#

10篇内容 | 1351人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2201253, encodeId=4257220125356, content=<a href='/topic/show?id=0edf6246874' target=_blank style='color:#2F92EE;'>#梗阻性肥厚型心肌病#</a>, objectTitle=梗阻性肥厚型心肌病新希望，全球首创心肌肌球蛋白抑制剂玛伐凯泰胶囊在中国获批, objectType=article, longId=823388, objectId=10048233886f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668021996705_4754896.webp, objectUrl=/article/show_article.do?id=10048233886f, replyNumber=0, likeNumber=0, createdTime=2024-04-30, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=10048233886f, moduleTitle=梗阻性肥厚型心肌病新希望，全球首创心肌肌球蛋白抑制剂玛伐凯泰胶囊在中国获批, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=10048233886f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1642243, encodeId=13741642243bf, content=<a href='/topic/show?id=0edf6246874' target=_blank style='color:#2F92EE;'>#梗阻性肥厚型心肌病#</a>, objectTitle=新一代心肌肌球蛋白抑制剂aficamten在中国获得3期临床试验申请批准，用于治疗症状性梗阻性肥厚型心肌病, objectType=article, longId=730815, objectId=f09be30815b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f09be30815b3, replyNumber=0, likeNumber=94, createdTime=2022-12-17, rootId=0, userName=dlwang_26703134, userId=f04b22885869, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f09be30815b3, moduleTitle=新一代心肌肌球蛋白抑制剂aficamten在中国获得3期临床试验申请批准，用于治疗症状性梗阻性肥厚型心肌病, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f09be30815b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1642241, encodeId=e5ac164224140, content=<a href='/topic/show?id=0edf6246874' target=_blank style='color:#2F92EE;'>#梗阻性肥厚型心肌病#</a>, objectTitle=EXPLORER-CN 3期临床试验：Mavacamten治疗有症状的梗阻性肥厚型心肌病在中国完成首例患者给药, objectType=article, longId=293854, objectId=d952293854cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d952293854cb, replyNumber=0, likeNumber=90, createdTime=2022-08-02, rootId=0, userName=dlwang_26703134, userId=f04b22885869, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d952293854cb, moduleTitle=EXPLORER-CN 3期临床试验：Mavacamten治疗有症状的梗阻性肥厚型心肌病在中国完成首例患者给药, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d952293854cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1642244, encodeId=fd951642244a3, content=<a href='/topic/show?id=0edf6246874' target=_blank style='color:#2F92EE;'>#梗阻性肥厚型心肌病#</a>, objectTitle=联拓生物完成Mavacamten用于治疗中国梗阻性肥厚型心肌病患者的EXPLORER-CN III期关键临床试验的患者招募, objectType=article, longId=735587, objectId=f431e3558751, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f431e3558751, replyNumber=0, likeNumber=98, createdTime=2023-04-06, rootId=0, userName=dlwang_26703134, userId=f04b22885869, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f431e3558751, moduleTitle=联拓生物完成Mavacamten用于治疗中国梗阻性肥厚型心肌病患者的EXPLORER-CN III期关键临床试验的患者招募, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f431e3558751)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1642242, encodeId=06a21642242db, content=<a href='/topic/show?id=0edf6246874' target=_blank style='color:#2F92EE;'>#梗阻性肥厚型心肌病#</a>, objectTitle=Mavacamten获中国“突破性治疗药物”认证，用于治疗梗阻性肥厚型心肌病, objectType=article, longId=298944, objectId=f5d829894405, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5d829894405, replyNumber=0, likeNumber=102, createdTime=2022-08-14, rootId=0, userName=dlwang_26703134, userId=f04b22885869, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5d829894405, moduleTitle=Mavacamten获中国“突破性治疗药物”认证，用于治疗梗阻性肥厚型心肌病, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f5d829894405)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1642239, encodeId=974016422390b, content=<a href='/topic/show?id=0edf6246874' target=_blank style='color:#2F92EE;'>#梗阻性肥厚型心肌病#</a>, objectTitle=JACC：梗阻性肥厚型心肌病患者的心肌组织病理与临床特征的相关性, objectType=article, longId=210818, objectId=f20c210818b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f20c210818b5, replyNumber=0, likeNumber=79, createdTime=2022-01-30, rootId=0, userName=dlwang_26703134, userId=f04b22885869, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f20c210818b5, moduleTitle=JACC：梗阻性肥厚型心肌病患者的心肌组织病理与临床特征的相关性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f20c210818b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1642240, encodeId=9ab016422401e, content=<a href='/topic/show?id=0edf6246874' target=_blank style='color:#2F92EE;'>#梗阻性肥厚型心肌病#</a>, objectTitle=Lancet：Mavacamten可明显改善梗阻性肥厚型心肌病患者的健康状况, objectType=article, longId=211560, objectId=b35921156090, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b35921156090, replyNumber=0, likeNumber=85, createdTime=2021-12-18, rootId=0, userName=dlwang_26703134, userId=f04b22885869, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b35921156090, moduleTitle=Lancet：Mavacamten可明显改善梗阻性肥厚型心肌病患者的健康状况, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b35921156090)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1642238, encodeId=adfa1642238b7, content=<a href='/topic/show?id=0edf6246874' target=_blank style='color:#2F92EE;'>#梗阻性肥厚型心肌病#</a>, objectTitle=Lancet：心肌肌球蛋白抑制剂Mavacamten治疗梗阻性肥厚型心肌病！, objectType=article, longId=200122, objectId=01d820012261, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01d820012261, replyNumber=0, likeNumber=92, createdTime=2021-04-26, rootId=0, userName=dlwang_26703134, userId=f04b22885869, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01d820012261, moduleTitle=Lancet：心肌肌球蛋白抑制剂Mavacamten治疗梗阻性肥厚型心肌病！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=01d820012261)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1642237, encodeId=0c69164223e42, content=<a href='/topic/show?id=0edf6246874' target=_blank style='color:#2F92EE;'>#梗阻性肥厚型心肌病#</a>, objectTitle=心肌声学造影指导经皮腔内室间隔心肌消融治疗梗阻性肥厚型心肌病1例, objectType=article, longId=184362, objectId=f4171843628d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4171843628d, replyNumber=0, likeNumber=86, createdTime=2020-02-24, rootId=0, userName=dlwang_26703134, userId=f04b22885869, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4171843628d, moduleTitle=心肌声学造影指导经皮腔内室间隔心肌消融治疗梗阻性肥厚型心肌病1例, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f4171843628d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1642236, encodeId=0e8c16422361c, content=<a href='/topic/show?id=0edf6246874' target=_blank style='color:#2F92EE;'>#梗阻性肥厚型心肌病#</a>, objectTitle=JAMA Cardiol：梗阻性肥厚型心肌病室间隔切除术后生存率的性别差异, objectType=article, longId=161844, objectId=5e24161844b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e24161844b8, replyNumber=0, likeNumber=72, createdTime=2019-06-17, rootId=0, userName=dlwang_26703134, userId=f04b22885869, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e24161844b8, moduleTitle=JAMA Cardiol：梗阻性肥厚型心肌病室间隔切除术后生存率的性别差异, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5e24161844b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1642235, encodeId=13e01642235a1, content=<a href='/topic/show?id=0edf6246874' target=_blank style='color:#2F92EE;'>#梗阻性肥厚型心肌病#</a>, objectTitle=SCI REP：梗阻性肥厚型心肌病患者室间隔酒精消融术后并发症和长期结局如何？, objectType=article, longId=111159, objectId=f3eb111159a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3eb111159a2, replyNumber=0, likeNumber=62, createdTime=2018-03-23, rootId=0, userName=dlwang_26703134, userId=f04b22885869, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3eb111159a2, moduleTitle=SCI REP：梗阻性肥厚型心肌病患者室间隔酒精消融术后并发症和长期结局如何？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f3eb111159a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

梗阻性肥厚型心肌病

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#梗阻性肥厚型心肌病#

梗阻性肥厚型心肌病新希望，全球首创心肌肌球蛋白抑制剂玛伐凯泰胶囊在中国获批

2024-04-30发表于上海

dlwang_26703134 (审核中...)

前往app查看评论内容

#梗阻性肥厚型心肌病#

新一代心肌肌球蛋白抑制剂aficamten在中国获得3期临床试验申请批准，用于治疗症状性梗阻性肥厚型心肌病

2022-12-17

dlwang_26703134 (审核中...)

前往app查看评论内容

#梗阻性肥厚型心肌病#

EXPLORER-CN 3期临床试验：Mavacamten治疗有症状的梗阻性肥厚型心肌病在中国完成首例患者给药

2022-08-02

dlwang_26703134 (审核中...)

前往app查看评论内容

#梗阻性肥厚型心肌病#

联拓生物完成Mavacamten用于治疗中国梗阻性肥厚型心肌病患者的EXPLORER-CN III期关键临床试验的患者招募

2023-04-06

dlwang_26703134 (审核中...)

前往app查看评论内容

#梗阻性肥厚型心肌病#

Mavacamten获中国“突破性治疗药物”认证，用于治疗梗阻性肥厚型心肌病

2022-08-14

dlwang_26703134 (审核中...)

前往app查看评论内容

#梗阻性肥厚型心肌病#

JACC：梗阻性肥厚型心肌病患者的心肌组织病理与临床特征的相关性

2022-01-30

dlwang_26703134 (审核中...)

前往app查看评论内容

#梗阻性肥厚型心肌病#

Lancet：Mavacamten可明显改善梗阻性肥厚型心肌病患者的健康状况

2021-12-18

dlwang_26703134 (审核中...)

前往app查看评论内容

#梗阻性肥厚型心肌病#

Lancet：心肌肌球蛋白抑制剂Mavacamten治疗梗阻性肥厚型心肌病！

2021-04-26

dlwang_26703134 (审核中...)

前往app查看评论内容

#梗阻性肥厚型心肌病#

心肌声学造影指导经皮腔内室间隔心肌消融治疗梗阻性肥厚型心肌病1例

2020-02-24

dlwang_26703134 (审核中...)

前往app查看评论内容

#梗阻性肥厚型心肌病#

JAMA Cardiol：梗阻性肥厚型心肌病室间隔切除术后生存率的性别差异

2019-06-17

dlwang_26703134 (审核中...)

前往app查看评论内容

#梗阻性肥厚型心肌病#

SCI REP：梗阻性肥厚型心肌病患者室间隔酒精消融术后并发症和长期结局如何？

2018-03-23

科室
- - 订阅+
  - 更多科室
工具
服务